Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $7.87 and traded as low as $7.71. Alpha Teknova shares last traded at $7.77, with a volume of 420,861 shares trading hands.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. Zacks Research raised Alpha Teknova to a “hold” rating in a research report on Thursday, August 6th. TD Cowen boosted their price target on shares of Alpha Teknova from $7.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday, October 13th. BTIG Research upgraded shares of Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price objective for the company in a research note on Tuesday, August 11th. Wall Street Zen upgraded shares of Alpha Teknova from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Alpha Teknova in a report on Wednesday, November 4th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $8.75.
Get Our Latest Stock Report on TKNO
Alpha Teknova Price Performance
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The firm had revenue of $12.70 million for the quarter, compared to analyst estimates of $11.71 million. Alpha Teknova had a negative net margin of 34.76% and a negative return on equity of 24.95%. Equities analysts predict that Alpha Teknova, Inc. will post -0.27 EPS for the current fiscal year.
Hedge Funds Weigh In On Alpha Teknova
Large investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of Alpha Teknova during the 2nd quarter valued at $4,997,000. Bank of America Corp DE acquired a new position in shares of Alpha Teknova in the 2nd quarter valued at $1,453,000. Bank of New York Mellon Corp acquired a new position in shares of Alpha Teknova in the 2nd quarter valued at $604,000. Empowered Funds LLC bought a new position in shares of Alpha Teknova in the 3rd quarter worth $656,000. Finally, GSA Capital Partners LLP bought a new position in shares of Alpha Teknova in the 2nd quarter worth $303,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.
Alpha Teknova Company Profile
Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.
Featured Stories
- Five stocks we like better than Alpha Teknova
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
